Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro

Author:

Selvarajan Ilakya1ORCID,Kiema Miika1ORCID,Huang Ru-Ting2ORCID,Li Jin2,Zhu Jiayu2ORCID,Pölönen Petri3,Örd Tiit1,Õunap Kadri1,Godiwala Mehvash1,Golebiewski Anna Kathryn4,Ravindran Aarthi1,Mäklin Kiira1,Toropainen Anu1,Stolze Lindsey K.4,Arce Maximiliano5ORCID,Magnusson Peetra U.5ORCID,White Stephen6ORCID,Romanoski Casey E.4ORCID,Heinäniemi Merja3ORCID,Laakkonen Johanna P.1ORCID,Fang Yun2ORCID,Kaikkonen Minna U.1ORCID

Affiliation:

1. A.I. Virtanen Institute for Molecular Sciences (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.U.K.), University of Eastern Finland, Kuopio.

2. Department of Medicine, The University of Chicago, IL (R.-T.H., J.L., J.Z., Y.F.).

3. Institute of Biomedicine, School of Medicine (P.P., M.H.), University of Eastern Finland, Kuopio.

4. Department of Cellular and Molecular Medicine, College of Medicine, The University of Arizona, Tucson (A.K.G., L.K.S., C.E.R.).

5. Department of Immunology, Genetics and Pathology, Uppsala University, Sweden (M.A., P.U.M.).

6. Faculty of Medical Sciences, Biosciences Institute, Newcastle University, United Kingdom (S.W.).

Abstract

BACKGROUND: CALCRL (calcitonin receptor-like) protein is an important mediator of the endothelial fluid shear stress response, which is associated with the genetic risk of coronary artery disease. In this study, we functionally characterized the noncoding regulatory elements carrying coronary artery disease that risks single-nucleotide polymorphisms and studied their role in the regulation of CALCRL expression in endothelial cells. METHODS: To functionally characterize the coronary artery disease single-nucleotide polymorphisms harbored around the gene CALCRL , we applied an integrative approach encompassing statistical, transcriptional (RNA-seq), and epigenetic (ATAC-seq [transposase-accessible chromatin with sequencing], chromatin immunoprecipitation assay-quantitative polymerase chain reaction, and electromobility shift assay) analyses, alongside luciferase reporter assays, and targeted gene and enhancer perturbations (siRNA and clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat–associated 9) in human aortic endothelial cells. RESULTS: We demonstrate that the regulatory element harboring rs880890 exhibits high enhancer activity and shows significant allelic bias. The A allele was favored over the G allele, particularly under shear stress conditions, mediated through alterations in the HSF1 (heat shock factor 1) motif and binding. CRISPR deletion of rs880890 enhancer resulted in downregulation of CALCRL expression, whereas HSF1 knockdown resulted in a significant decrease in rs880890-enhancer activity and CALCRL expression. A significant decrease in HSF1 binding to the enhancer region in endothelial cells was observed under disturbed flow compared with unidirectional flow. CALCRL knockdown and variant perturbation experiments indicated the role of CALCRL in mediating eNOS (endothelial nitric oxide synthase), APLN (apelin), angiopoietin, prostaglandins, and EDN1 (endothelin-1) signaling pathways leading to a decrease in cell proliferation, tube formation, and NO production. CONCLUSIONS: Overall, our results demonstrate the existence of an endothelial-specific HSF (heat shock factor)–regulated transcriptional enhancer that mediates CALCRL expression. A better understanding of CALCRL gene regulation and the role of single-nucleotide polymorphisms in the modulation of CALCRL expression could provide important steps toward understanding the genetic regulation of shear stress signaling responses.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3